A groundbreaking gene therapy trial has successfully restored hearing in children and adults with congenital deafness after just one injection.
The treatment delivers a healthy copy of the missing gene directly to the inner ear, enabling the brain to process sound waves for the first time.
This medical milestone offers a potential cure for hereditary hearing loss, transforming a lifetime of silence into a world of sound within weeks.
Researchers hope that with further development, this therapy will become widely available and change millions of lives.
This breakthrough marks a promising future for those affected by hearing impairments.